Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",heart pumping trait,,RS:0000374,GH/Omr,male,146 days to 132 days,14,,CMO:0003904,change in heart rate to change in vasoactive chemical dose ratio,,"change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg)",,-0.87,(beats/min)/(ug/kg),0.0668,0.25,MMO:0000011,vascular indwelling catheter method,,0.0,ng/kg/min,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),138468,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),phenylephrine (4 ug/kg) (between 0 and 0 hours) 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",heart pumping trait,,RS:0001665,BN.GH-(D18Rat41-D18Mgh4)/Mcwi,male,146 days to 132 days,11,,CMO:0003904,change in heart rate to change in vasoactive chemical dose ratio,,"change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg)",,-1.25,(beats/min)/(ug/kg),0.0513,0.17,MMO:0000011,vascular indwelling catheter method,,0.0,ng/kg/min,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),138469,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),phenylephrine (4 ug/kg) (between 0 and 0 hours) 101,"Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99.",heart pumping trait,,RS:0000137,BN/Elh,male,146 days to 132 days,14,,CMO:0003904,change in heart rate to change in vasoactive chemical dose ratio,,"change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg)",,-2.28,(beats/min)/(ug/kg),0.0695,0.26,MMO:0000011,vascular indwelling catheter method,,0.0,ng/kg/min,,,,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours),138470,angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours),norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours),phenylephrine (4 ug/kg) (between 0 and 0 hours)